CClinicalTrials.gg
CompletedNCT01710891Updated Mar 15, 2019Results posted

Laryngoscope Versus CMAC for Endotracheal Intubation in Patients Undergoing Emergent Airway Management

A Phase 4 interventional study of CMAC videolaryngoscope and Direct Laryngoscopy in Acute Respiratory Distress, sponsored by Hennepin Healthcare Research Institute. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2019-03-15.

Sponsored by Hennepin Healthcare Research Institute · Phase 4, Interventional, and Treatment

Phase
Phase 4
Study type
Interventional
Enrollment
198
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Randomized controlled trial of intubation using the C-MAC video laryngoscope versus standard laryngoscopy. Patients who are going to be intubated using standard laryngoscopy will be randomized to have their first intubation attempt done using either standard laryngoscopy or the C-MAC video laryngoscope. Subsequent attempts will be at the discretion of the treating physician.

Read the detailed description

Experimental Design and Methods:

This will be a prospective randomized controlled trial of intubation using the C-MAC video laryngoscope versus standard laryngoscopy for patients requiring emergent intubation in the Emergency Department.

Study Setting and Population:

This study will be performed at an urban county medical center with approximately 97,000 patient visits per year. Adult patients (age >17) requiring intubation will be enrolled.

Study Protocol:

All ED patients who are unable to adequately breathe on their own requiring emergent intubation for airway management will be screened for inclusion in the study. Identified patients will be deemed eligible when the need for intubation has been determined by the treating physician. Eligible patients will be placed on capnograph, cardiac, blood pressure and pulse oximetry monitors. Patients will be randomly assigned to be intubated using standard laryngoscopy with the C-MAC blade or C-MAC videolaryngoscope. Sealed envelopes containing the randomization assignment for the treatment groups will be kept at the patient's bedside in the stabilization room. Patients will be monitored by oxygen saturation, blood pressure, heart rate, and respiratory rate, which are typical for patients requiring intubation in our ED. Data will be recorded every minute by a trained research assistant at the patient's bedside. The lowest oxygen saturation during the procedure will be recorded for determination of hypoxia. Hypoxia will be defined as an oxygen saturation \<93%. The number of attempts made to intubate and the total time to successful intubation will be recorded. An attempt starts when the intubating device enters the patients mouth and ends when the endotracheal tube placement is confirmed or when a new intubating device is put in the patients mouth after the previous device had been removed. Data collection includes the timing and number of breaths given via Bag-Valve-Mask and patient repositioning between the attempts. All treatments will be recorded. Data collection will continue until the patient is discharged from the Emergency Department. The patient's diagnosis at the time of discharge from the ED will be recorded. Patients' charts will be reviewed to determine the diagnosis, occurrence of aspiration pneumonia, ICU length of stay, and inpatient length of stay. Two attempts will be made to contact patients 28 days after study enrollment to determine their condition at that time.

Data Analysis:

Data will be collected by a designated research assistant during the procedure and will then be entered into an EXCEL (Microsoft Corp., Redmond, WA) database for storage. Data will be exported into STATA 10.0 (STATA Corp., College Station, TX) for further analysis. The number of attempts to successful intubation and total time to intubation will be compared using descriptive statistics. Occurrence of hypoxia and aspiration pneumonia will be compared in patients who were intubated with the C-MAC to patients intubated with standard laryngoscopy using Chi-Square tests. Oxygen saturation, ETCO2, and heart rate will be compared in both groups using multiple linear regression.

The length of stay and 28 day follow up between the two groups will be compared using Wilcoxon rank sum tests. In order to detect a 15% difference in the length of stay between the two groups, with a power of 80% and an alpha of 0.05, 100 patients will be required in each group for a total of 200 patients.

02

Conditions studied

  • Acute Respiratory Distress

Keywords

  • endotracheal intubation
  • direct laryngoscopy
  • video laryngoscopy
03

In context

Lead sponsor

Hennepin Healthcare Research Institute is the lead sponsor of 69 studies on the registry; 4 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adult patients (age >17) requiring emergent endotracheal intubation in the Emergency Department using direct laryngoscopy

Exclusion criteria

Exclusion Criteria:

  • Physician intends to intubate with a device other than a direct laryngoscope
05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
198 participants (actual)

Study arms

  • Active comparator
    Direct Laryngoscopy

    Patients will undergo their first intubation attempt with direct laryngoscopy using the CMAC device without video assistance. The video monitor with be covered with a hood.

    Procedure: Direct Laryngoscopy

  • Experimental
    CMAC

    Patients will undergo their first intubation attempt using the CMAC videolaryngoscope using video assistance

    Procedure: CMAC videolaryngoscope

Interventions

  • ProcedureCMAC videolaryngoscope

    patients are intubated using the CMAC video laryngoscope

  • ProcedureDirect Laryngoscopy

    Patients undergo their first intubation attempt using direct laryngoscopy with a C-MAC device with the video display covered with a hood.

06

What researchers measure

Primary outcomes

  1. First Pass Success in Patients Undergoing Emergency Intubation, Intubated With Either Direct Larynogoscopy or Video Laryngoscopy Using a C-MAC Device.

    An attempt is counted as the intubating device entering the patients mouth until it is removed. Intubation success is defined as the endotracheal tube being placed in the patients lungs as confirmed by auscultation and end tidal carbon dioxide

    Time frame: During intubation procedure up to 1 hour

  2. Time to Intubation

    The time in seconds from the time at which the intubating device is first placed in the patient's mouth until the time of successful intubation

    Time frame: From the time the first device entered the patients mouth until successful intubation up to 1 hour

Secondary outcomes

  1. Length of Stay

    The time in days from hospital admission until discharge.

    Time frame: From the time of hospital admission until discharge up to 28 days

  2. Aspiration Pneumonia

    The occurrence of aspiration pneumonia as defined by the clinical diagnosis in the patients chart and or radiographic determination of aspiration during the 28 days after the intubation procedure

    Time frame: from the time of hospital admission up to 28 days

  3. Incidence of Hypoxia

    Oxygen saturations will be recorded during the procedure, oxygen saturation less than 93% will be considered an occurrence of hypoxia

    Time frame: From the start of the procedure until successful intubation up to 1 hour

  4. Failed Intubation

    Defined as the operator switching to an alternate device or intubation technique after at least one unsuccessful intubation attempt.

    Time frame: from the start of the procedure until successful intubation up to one hour

07

Results

Posted Mar 15, 2019

Participant flow

Participant flow — Overall Study
MilestoneDirect LaryngoscopyCMAC
Started95103
Completed95103
Not completed00

Outcome measures

PrimaryFirst Pass Success in Patients Undergoing Emergency Intubation, Intubated With Either Direct Larynogoscopy or Video Laryngoscopy Using a C-MAC Device.

An attempt is counted as the intubating device entering the patients mouth until it is removed. Intubation success is defined as the endotracheal tube being placed in the patients lungs as confirmed by auscultation and end tidal carbon dioxide

Time frame:
During intubation procedure up to 1 hour
Reported as:
Number · percentage of participants
First Pass Success in Patients Undergoing Emergency Intubation, Intubated With Either Direct Larynogoscopy or Video Laryngoscopy Using a C-MAC Device.
percentage of participantsDirect LaryngoscopyCMAC
First Pass Success in Patients Undergoing Emergency Intubation, Intubated With Either Direct Larynogoscopy or Video Laryngoscopy Using a C-MAC Device.86.3 (79.2 to 93.4)92.2 (87.0 to 97.5)
PrimaryTime to Intubation

The time in seconds from the time at which the intubating device is first placed in the patient's mouth until the time of successful intubation

Time frame:
From the time the first device entered the patients mouth until successful intubation up to 1 hour
Reported as:
Mean · Seconds
Time to Intubation
SecondsDirect LaryngoscopyCMAC
Time to Intubation58 (49 to 69)61 (46 to 77)
SecondaryLength of Stay

The time in days from hospital admission until discharge.

Time frame:
From the time of hospital admission until discharge up to 28 days
Reported as:
Median · Days
Length of Stay
DaysDirect LaryngoscopyCMAC
Length of Stay9.1 (6.6 to 11.5)8.5 (6.6 to 10.3)
SecondaryAspiration Pneumonia

The occurrence of aspiration pneumonia as defined by the clinical diagnosis in the patients chart and or radiographic determination of aspiration during the 28 days after the intubation procedure

Time frame:
from the time of hospital admission up to 28 days
Reported as:
Number · Percentage of Aspiration Pneumonia
Aspiration Pneumonia
Percentage of Aspiration PneumoniaDirect LaryngoscopyCMAC
Aspiration Pneumonia12.2 (5.3 to 19.1)7.2 (2.0 to 12.6)
SecondaryIncidence of Hypoxia

Oxygen saturations will be recorded during the procedure, oxygen saturation less than 93% will be considered an occurrence of hypoxia

Time frame:
From the start of the procedure until successful intubation up to 1 hour
Reported as:
Number · Percentage of Hypoxemia
Incidence of Hypoxia
Percentage of HypoxemiaDirect LaryngoscopyCMAC
Incidence of Hypoxia27.3 (18.4 to 36.3)25.2 (16.9 to 33.6)
SecondaryFailed Intubation

Defined as the operator switching to an alternate device or intubation technique after at least one unsuccessful intubation attempt.

Time frame:
from the start of the procedure until successful intubation up to one hour
Reported as:
Number · percentage of participants
Failed Intubation
percentage of participantsDirect LaryngoscopyCMAC
Failed Intubation61.525

Adverse events

Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Direct Laryngoscopy—0/95 (0%)0/95 (0%)
CMAC—0/103 (0%)0/103 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Direct LaryngoscopyCMACTotal
Mean51.6 (19 to 88)52.6 (19 to 86)52.1 (19 to 88)
Sex: Female, Male
Sex: Female, Male(Participants)Direct LaryngoscopyCMACTotal
Female324173
Male6362125
Region of Enrollment
Region of Enrollment(participants)Direct LaryngoscopyCMACTotal
United States95103198
08

Study locations

1 site
  • Hennepin County Medical Center
    Minneapolis, Minnesota 55415, United States
09

References and documents

Publications

  • Driver BE, Prekker ME, Moore JC, Schick AL, Reardon RF, Miner JR. Direct Versus Video Laryngoscopy Using the C-MAC for Tracheal Intubation in the Emergency Department, a Randomized Controlled Trial. Acad Emerg Med. 2016 Apr;23(4):433-9. doi: 10.1111/acem.12933. Epub 2016 Mar 24. PubMed 26850232 ↗
10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 15, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT01710891
Lead sponsor
Hennepin Healthcare Research Institute
Responsible party
Sponsor
First posted
Oct 19, 2012
Start date
Oct 2011
Primary completion
Jun 2013
Completion
Jun 2013
Results posted
Mar 15, 2019
Last update
Mar 15, 2019

Study contacts

James R Miner, MD
principal investigator · Hennepin Healthcare Research Institute

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion